125 related articles for article (PubMed ID: 32935545)
41. Urinary metabolites of nobiletin orally administered to rats.
Yasuda T; Yoshimura Y; Yabuki H; Nakazawa T; Ohsawa K; Mimaki Y; Sashida Y
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1426-8. PubMed ID: 14646323
[TBL] [Abstract][Full Text] [Related]
42. Identification of nobiletin metabolites in mouse urine.
Li S; Wang Z; Sang S; Huang MT; Ho CT
Mol Nutr Food Res; 2006 Mar; 50(3):291-9. PubMed ID: 16521176
[TBL] [Abstract][Full Text] [Related]
43. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.
Shen J; Bi J; Tian H; Jin Y; Wang Y; Yang X; Yang Z; Kou J; Li F
Int J Nanomedicine; 2016; 11():4919-4929. PubMed ID: 27713630
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes Versus Self-Nanoemulsifying Drug Delivery System.
Nekkanti V; Wang Z; Betageri GV
AAPS PharmSciTech; 2016 Aug; 17(4):851-62. PubMed ID: 26381913
[TBL] [Abstract][Full Text] [Related]
45. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
[TBL] [Abstract][Full Text] [Related]
46. Melatonin loaded with bacterial cellulose nanofiber by Pickering-emulsion solvent evaporation for enhanced dissolution and bioavailability.
Li Y; Zhao X; Liu Y; Yang J; Zhang Q; Wang L; Wu W; Yang Q; Liu B
Int J Pharm; 2019 Mar; 559():393-401. PubMed ID: 30731257
[TBL] [Abstract][Full Text] [Related]
47. Nobiletin alleviates vascular alterations through modulation of Nrf-2/HO-1 and MMP pathways in l-NAME induced hypertensive rats.
Potue P; Wunpathe C; Maneesai P; Kukongviriyapan U; Prachaney P; Pakdeechote P
Food Funct; 2019 Apr; 10(4):1880-1892. PubMed ID: 30864566
[TBL] [Abstract][Full Text] [Related]
48. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
[TBL] [Abstract][Full Text] [Related]
49. Correction to Assessment of Oral Bioavailability and Biotransformation of Emulsified Nobiletin Using
Zhang M; Feng K; Huang G; Xin Y; Xiao J; Cao Y; Ludescher R; Ho CT; Huang Q
J Agric Food Chem; 2020 Nov; 68(44):12503. PubMed ID: 33089681
[No Abstract] [Full Text] [Related]
50. Nano-sized Droplets of Self-Emulsifying System for Enhancing Oral Bioavailability of Chemotherapeutic Agent VP-16 in Rats: A Nano Lipid Carrier for BCS Class IV Drugs.
Khalid N; Sarfraz M; Arafat M; Akhtar M; Löbenberg R; Ur Rehman N
J Pharm Pharm Sci; 2018; 21(1):398-408. PubMed ID: 30365396
[TBL] [Abstract][Full Text] [Related]
51. A review on recent advances on nobiletin in central and peripheral nervous system diseases.
Pang Y; Xiong J; Wu Y; Ding W
Eur J Med Res; 2023 Nov; 28(1):485. PubMed ID: 37932838
[TBL] [Abstract][Full Text] [Related]
52. Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: In vitro and in vivo evaluations.
Kim BK; Cho AR; Park DJ
Food Chem; 2016 Sep; 206():85-91. PubMed ID: 27041302
[TBL] [Abstract][Full Text] [Related]
53. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
Alhnan MA; Murdan S; Basit AW
Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
[TBL] [Abstract][Full Text] [Related]
54. Nobiletin Inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in a rat carotid artery injury model.
Guan S; Tang Q; Liu W; Zhu R; Li B
Drug Dev Res; 2014 Dec; 75(8):489-96. PubMed ID: 25452110
[TBL] [Abstract][Full Text] [Related]
55. Paeonol nanoemulsion for enhanced oral bioavailability: optimization and mechanism.
Chen S; Zhang J; Wu L; Wu H; Dai M
Nanomedicine (Lond); 2018 Feb; 13(3):269-282. PubMed ID: 29338580
[TBL] [Abstract][Full Text] [Related]
56. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogs.
Araya H; Nagao S; Tomita M; Hayashi M
Drug Metab Pharmacokinet; 2005 Aug; 20(4):244-56. PubMed ID: 16141604
[TBL] [Abstract][Full Text] [Related]
57. The influence of droplet size on the stability, in vivo digestion, and oral bioavailability of vitamin E emulsions.
Parthasarathi S; Muthukumar SP; Anandharamakrishnan C
Food Funct; 2016 May; 7(5):2294-302. PubMed ID: 27101870
[TBL] [Abstract][Full Text] [Related]
58. In vivo postprandial bioavailability of interesterified-lipids in sodium-caseinate or chitosan based O/W emulsions.
Farfán M; Villalón MJ; Ortíz ME; Nieto S; Bouchon P
Food Chem; 2015 Mar; 171():266-71. PubMed ID: 25308668
[TBL] [Abstract][Full Text] [Related]
59. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
Gabr MM; Mortada SM; Sallam MA
J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
[TBL] [Abstract][Full Text] [Related]
60. Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique.
Choi YK; Poudel BK; Marasini N; Yang KY; Kim JW; Kim JO; Choi HG; Yong CS
Int J Pharm; 2012 Sep; 434(1-2):264-71. PubMed ID: 22643224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
